Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 21 | 2019 | 60 | 2.090 |
Why?
|
Environmental Exposure | 11 | 2015 | 92 | 1.450 |
Why?
|
Chromatography, High Pressure Liquid | 14 | 2019 | 96 | 1.310 |
Why?
|
Cotinine | 7 | 2018 | 49 | 1.200 |
Why?
|
Smoking | 7 | 2018 | 493 | 1.090 |
Why?
|
Trans Fatty Acids | 2 | 2017 | 10 | 1.000 |
Why?
|
Nutritional Status | 2 | 2017 | 73 | 1.000 |
Why?
|
United States | 30 | 2020 | 3983 | 0.940 |
Why?
|
Disease Outbreaks | 3 | 2019 | 38 | 0.910 |
Why?
|
Environmental Monitoring | 10 | 2014 | 28 | 0.890 |
Why?
|
Nutrition Surveys | 7 | 2017 | 149 | 0.880 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2019 | 77 | 0.860 |
Why?
|
Urinalysis | 5 | 2020 | 27 | 0.850 |
Why?
|
Botulinum Toxins | 9 | 2012 | 37 | 0.840 |
Why?
|
Nicotine | 3 | 2020 | 171 | 0.760 |
Why?
|
Chromatography, Liquid | 11 | 2018 | 43 | 0.740 |
Why?
|
Adult | 31 | 2020 | 9467 | 0.730 |
Why?
|
Creatinine | 5 | 2019 | 200 | 0.730 |
Why?
|
Peritoneal Dialysis | 3 | 2020 | 26 | 0.700 |
Why?
|
Humans | 65 | 2020 | 32297 | 0.690 |
Why?
|
Kidney Failure, Chronic | 4 | 2020 | 541 | 0.690 |
Why?
|
Lung Injury | 1 | 2019 | 66 | 0.670 |
Why?
|
Glucuronides | 1 | 2018 | 2 | 0.640 |
Why?
|
Hypoglycins | 5 | 2018 | 5 | 0.630 |
Why?
|
Middle Aged | 24 | 2020 | 11949 | 0.630 |
Why?
|
Glycine | 5 | 2018 | 27 | 0.630 |
Why?
|
Cyclopropanes | 5 | 2018 | 20 | 0.630 |
Why?
|
Female | 37 | 2020 | 20126 | 0.620 |
Why?
|
Tobacco Smoke Pollution | 5 | 2010 | 41 | 0.610 |
Why?
|
Ultrafiltration | 1 | 2017 | 9 | 0.600 |
Why?
|
Nitrosamines | 4 | 2010 | 11 | 0.590 |
Why?
|
Hypotension | 1 | 2017 | 49 | 0.570 |
Why?
|
Fasting | 1 | 2017 | 97 | 0.570 |
Why?
|
Young Adult | 11 | 2020 | 2626 | 0.560 |
Why?
|
Dietary Fats | 1 | 2017 | 110 | 0.560 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2012 | 27 | 0.550 |
Why?
|
Diet | 3 | 2017 | 384 | 0.550 |
Why?
|
Adolescent | 20 | 2020 | 3571 | 0.540 |
Why?
|
Male | 32 | 2020 | 19488 | 0.540 |
Why?
|
Mass Spectrometry | 9 | 2017 | 105 | 0.530 |
Why?
|
Hyperkalemia | 1 | 2015 | 13 | 0.530 |
Why?
|
Pyridines | 3 | 2010 | 81 | 0.530 |
Why?
|
Hypoglycemia | 1 | 2015 | 46 | 0.510 |
Why?
|
Hematinics | 1 | 2014 | 6 | 0.500 |
Why?
|
Environmental Pollutants | 4 | 2014 | 20 | 0.490 |
Why?
|
Organic Chemicals | 2 | 2011 | 7 | 0.490 |
Why?
|
Solid Phase Extraction | 4 | 2014 | 4 | 0.490 |
Why?
|
Renal Dialysis | 1 | 2017 | 282 | 0.480 |
Why?
|
Glucose | 1 | 2015 | 177 | 0.480 |
Why?
|
Anemia | 1 | 2014 | 60 | 0.480 |
Why?
|
Sodium Chloride, Dietary | 1 | 2014 | 29 | 0.470 |
Why?
|
Aged | 16 | 2020 | 10398 | 0.470 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 5 | 2011 | 5 | 0.450 |
Why?
|
Immune Complex Diseases | 1 | 2013 | 2 | 0.450 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 18 | 0.450 |
Why?
|
Insulin | 1 | 2015 | 368 | 0.450 |
Why?
|
Hematuria | 1 | 2012 | 11 | 0.440 |
Why?
|
Lupus Nephritis | 1 | 2013 | 30 | 0.440 |
Why?
|
Lactobacillus | 1 | 2012 | 14 | 0.430 |
Why?
|
Patient Compliance | 1 | 2014 | 227 | 0.430 |
Why?
|
European Continental Ancestry Group | 4 | 2012 | 1180 | 0.420 |
Why?
|
Endopeptidases | 5 | 2012 | 26 | 0.420 |
Why?
|
Blood Chemical Analysis | 6 | 2020 | 23 | 0.370 |
Why?
|
Amino Acid Sequence | 16 | 2017 | 287 | 0.370 |
Why?
|
Reproducibility of Results | 9 | 2019 | 779 | 0.360 |
Why?
|
Proteomics | 5 | 2016 | 94 | 0.340 |
Why?
|
Antigens, Bacterial | 4 | 2011 | 18 | 0.330 |
Why?
|
Trypsin | 4 | 2017 | 12 | 0.330 |
Why?
|
Child | 13 | 2017 | 2472 | 0.330 |
Why?
|
Cataract | 1 | 2008 | 10 | 0.320 |
Why?
|
Carcinogens | 5 | 2010 | 36 | 0.320 |
Why?
|
Fruit | 3 | 2018 | 53 | 0.320 |
Why?
|
Zinc | 1 | 2008 | 32 | 0.320 |
Why?
|
Macular Degeneration | 1 | 2008 | 22 | 0.320 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 110 | 0.310 |
Why?
|
Antioxidants | 1 | 2008 | 114 | 0.300 |
Why?
|
Influenza Vaccines | 4 | 2014 | 79 | 0.300 |
Why?
|
Viral Proteins | 3 | 2014 | 42 | 0.300 |
Why?
|
Sapindus | 2 | 2018 | 2 | 0.290 |
Why?
|
Reference Values | 6 | 2019 | 255 | 0.290 |
Why?
|
Molecular Sequence Data | 13 | 2014 | 359 | 0.290 |
Why?
|
Hypertension | 1 | 2014 | 972 | 0.280 |
Why?
|
Ricin | 3 | 2011 | 4 | 0.280 |
Why?
|
Antibodies, Monoclonal | 4 | 2011 | 250 | 0.260 |
Why?
|
Bacterial Toxins | 3 | 2011 | 16 | 0.260 |
Why?
|
Public Health | 2 | 2011 | 83 | 0.260 |
Why?
|
Apolipoproteins | 2 | 2018 | 200 | 0.250 |
Why?
|
Information Services | 1 | 2005 | 15 | 0.250 |
Why?
|
Maternal Exposure | 1 | 2004 | 13 | 0.250 |
Why?
|
Peptides | 6 | 2012 | 120 | 0.250 |
Why?
|
Pregnancy Outcome | 1 | 2004 | 91 | 0.240 |
Why?
|
Age Factors | 7 | 2013 | 1204 | 0.230 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 600 | 0.230 |
Why?
|
Tobacco | 3 | 2010 | 57 | 0.230 |
Why?
|
Sex Factors | 5 | 2013 | 674 | 0.230 |
Why?
|
Retrospective Studies | 3 | 2017 | 3514 | 0.220 |
Why?
|
Spectrum Analysis, Raman | 2 | 2020 | 9 | 0.220 |
Why?
|
Gas Chromatography-Mass Spectrometry | 3 | 2017 | 28 | 0.220 |
Why?
|
Neurotoxicity Syndromes | 2 | 2017 | 19 | 0.210 |
Why?
|
Vesicle-Associated Membrane Protein 2 | 2 | 2011 | 2 | 0.200 |
Why?
|
Magnesium Deficiency | 1 | 2020 | 1 | 0.190 |
Why?
|
Hemoglobins | 2 | 2014 | 49 | 0.190 |
Why?
|
Magnesium | 1 | 2020 | 30 | 0.190 |
Why?
|
Apolipoprotein B-100 | 2 | 2018 | 10 | 0.190 |
Why?
|
Apolipoprotein A-I | 2 | 2018 | 69 | 0.180 |
Why?
|
Sapindaceae | 2 | 2018 | 2 | 0.180 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 34 | 0.180 |
Why?
|
Vitamin E | 1 | 2019 | 23 | 0.180 |
Why?
|
Substance Abuse Detection | 1 | 2019 | 8 | 0.170 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 13 | 0.170 |
Why?
|
Catheterization | 1 | 2020 | 59 | 0.170 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 42 | 0.170 |
Why?
|
Reverse Transcriptase Inhibitors | 2 | 2009 | 7 | 0.170 |
Why?
|
Acute Lung Injury | 1 | 2019 | 32 | 0.170 |
Why?
|
Fentanyl | 1 | 2019 | 38 | 0.170 |
Why?
|
Influenza A Virus, H5N1 Subtype | 2 | 2009 | 3 | 0.170 |
Why?
|
Neurotoxins | 2 | 2012 | 16 | 0.170 |
Why?
|
Insecticides | 3 | 2004 | 20 | 0.170 |
Why?
|
Phospholipids | 1 | 2019 | 28 | 0.170 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 877 | 0.170 |
Why?
|
Cholesterol | 2 | 2018 | 251 | 0.170 |
Why?
|
Urine | 1 | 2019 | 68 | 0.170 |
Why?
|
Aged, 80 and over | 3 | 2020 | 4050 | 0.160 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 56 | 0.160 |
Why?
|
African Continental Ancestry Group | 3 | 2010 | 364 | 0.160 |
Why?
|
Asthma | 1 | 2002 | 438 | 0.160 |
Why?
|
Dyslipidemias | 1 | 2019 | 53 | 0.160 |
Why?
|
Anthrax | 2 | 2009 | 5 | 0.160 |
Why?
|
Fractionation, Field Flow | 1 | 2018 | 1 | 0.160 |
Why?
|
Calibration | 5 | 2019 | 27 | 0.160 |
Why?
|
Lipids | 2 | 2018 | 226 | 0.160 |
Why?
|
Laparoscopy | 1 | 2020 | 171 | 0.150 |
Why?
|
Lipoproteins | 1 | 2018 | 84 | 0.150 |
Why?
|
Botulism | 3 | 2012 | 9 | 0.150 |
Why?
|
Hydrogenation | 1 | 2017 | 1 | 0.150 |
Why?
|
Litchi | 1 | 2017 | 1 | 0.150 |
Why?
|
Blood Glucose | 2 | 2020 | 496 | 0.150 |
Why?
|
Isotope Labeling | 3 | 2011 | 17 | 0.140 |
Why?
|
Smoke | 2 | 2009 | 15 | 0.140 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 262 | 0.140 |
Why?
|
Influenza A virus | 2 | 2014 | 21 | 0.140 |
Why?
|
Cohort Studies | 2 | 2020 | 1832 | 0.140 |
Why?
|
Triglycerides | 1 | 2017 | 230 | 0.140 |
Why?
|
Occupational Exposure | 3 | 2004 | 238 | 0.140 |
Why?
|
Quality Control | 3 | 2018 | 43 | 0.130 |
Why?
|
Feeding Behavior | 1 | 2017 | 162 | 0.130 |
Why?
|
Clostridium botulinum | 2 | 2012 | 3 | 0.130 |
Why?
|
Prevalence | 1 | 2018 | 986 | 0.130 |
Why?
|
Neuraminidase | 2 | 2011 | 10 | 0.130 |
Why?
|
Linear Models | 3 | 2018 | 454 | 0.130 |
Why?
|
Child, Preschool | 5 | 2009 | 1281 | 0.130 |
Why?
|
Pregnancy | 3 | 2014 | 1010 | 0.130 |
Why?
|
Sex Distribution | 2 | 2014 | 201 | 0.130 |
Why?
|
Ethnic Groups | 4 | 2013 | 480 | 0.130 |
Why?
|
Erythropoietin | 1 | 2014 | 31 | 0.120 |
Why?
|
Cross-Sectional Studies | 4 | 2014 | 1522 | 0.120 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 309 | 0.120 |
Why?
|
Postoperative Complications | 1 | 2020 | 788 | 0.120 |
Why?
|
Influenza in Birds | 1 | 2014 | 3 | 0.120 |
Why?
|
Animals | 12 | 2015 | 7694 | 0.120 |
Why?
|
Substrate Specificity | 5 | 2012 | 90 | 0.120 |
Why?
|
Incidence | 2 | 2015 | 1207 | 0.120 |
Why?
|
Phenols | 1 | 2014 | 17 | 0.120 |
Why?
|
Peptide Fragments | 1 | 2017 | 422 | 0.120 |
Why?
|
California | 2 | 2004 | 64 | 0.120 |
Why?
|
Child Development | 1 | 2014 | 42 | 0.110 |
Why?
|
Trace Elements | 1 | 2013 | 7 | 0.110 |
Why?
|
Health Surveys | 1 | 2014 | 202 | 0.110 |
Why?
|
Nutrition Policy | 1 | 2013 | 35 | 0.110 |
Why?
|
Bacterial Proteins | 2 | 2010 | 79 | 0.110 |
Why?
|
Reagent Strips | 1 | 2012 | 4 | 0.110 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 90 | 0.110 |
Why?
|
False Positive Reactions | 1 | 2012 | 31 | 0.110 |
Why?
|
Vitamins | 1 | 2013 | 68 | 0.110 |
Why?
|
Atrazine | 1 | 2012 | 1 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2005 | 681 | 0.100 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2011 | 12 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 1428 | 0.100 |
Why?
|
Lead | 2 | 2009 | 6 | 0.100 |
Why?
|
Reference Standards | 4 | 2019 | 33 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2013 | 2296 | 0.100 |
Why?
|
Beverages | 1 | 2011 | 20 | 0.100 |
Why?
|
Castor Bean | 1 | 2011 | 1 | 0.100 |
Why?
|
Toxicology | 1 | 2011 | 6 | 0.100 |
Why?
|
Plant Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
Clostridium | 1 | 2010 | 4 | 0.100 |
Why?
|
Tars | 1 | 2010 | 3 | 0.100 |
Why?
|
Software | 1 | 2011 | 126 | 0.100 |
Why?
|
Chemical Warfare Agents | 1 | 2011 | 14 | 0.100 |
Why?
|
Risk | 1 | 2012 | 325 | 0.100 |
Why?
|
Polychlorinated Biphenyls | 3 | 2009 | 7 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2012 | 121 | 0.090 |
Why?
|
Risk Factors | 2 | 2017 | 3876 | 0.090 |
Why?
|
Glycosuria | 2 | 2020 | 3 | 0.090 |
Why?
|
Body Mass Index | 1 | 2014 | 921 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2019 | 696 | 0.090 |
Why?
|
Plant Extracts | 1 | 2011 | 61 | 0.090 |
Why?
|
Limit of Detection | 3 | 2018 | 15 | 0.090 |
Why?
|
Polyphosphates | 1 | 2009 | 1 | 0.090 |
Why?
|
Chromatography, Ion Exchange | 1 | 2009 | 4 | 0.090 |
Why?
|
Registries | 2 | 2020 | 300 | 0.090 |
Why?
|
Principal Component Analysis | 2 | 2020 | 68 | 0.090 |
Why?
|
Polyglutamic Acid | 1 | 2009 | 1 | 0.090 |
Why?
|
Biochemistry | 1 | 2009 | 1 | 0.090 |
Why?
|
Nucleotides | 1 | 2009 | 16 | 0.090 |
Why?
|
Nucleosides | 1 | 2009 | 10 | 0.090 |
Why?
|
Blood Pressure | 1 | 2014 | 859 | 0.090 |
Why?
|
Lead Poisoning | 1 | 2009 | 3 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 66 | 0.080 |
Why?
|
Air Pollution | 1 | 2009 | 18 | 0.080 |
Why?
|
Air Pollutants | 1 | 2009 | 21 | 0.080 |
Why?
|
Socioeconomic Factors | 3 | 2006 | 422 | 0.080 |
Why?
|
Isotopes | 3 | 2017 | 11 | 0.080 |
Why?
|
Conjunctivitis | 1 | 2008 | 3 | 0.080 |
Why?
|
Micronutrients | 1 | 2008 | 18 | 0.080 |
Why?
|
Complex Mixtures | 1 | 2008 | 3 | 0.080 |
Why?
|
Antigens, Viral | 1 | 2008 | 21 | 0.080 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 30 | 0.080 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 39 | 0.080 |
Why?
|
Orthomyxoviridae | 1 | 2008 | 14 | 0.080 |
Why?
|
Infant | 3 | 2009 | 1076 | 0.080 |
Why?
|
Regression Analysis | 2 | 2005 | 296 | 0.070 |
Why?
|
Anthrax Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
|
Thyroid Hormones | 1 | 2006 | 5 | 0.070 |
Why?
|
Proteins | 1 | 2008 | 150 | 0.070 |
Why?
|
Obesity | 1 | 2014 | 1164 | 0.070 |
Why?
|
Mexican Americans | 1 | 2006 | 60 | 0.070 |
Why?
|
Feces | 1 | 2006 | 36 | 0.070 |
Why?
|
Disease Progression | 1 | 2008 | 618 | 0.070 |
Why?
|
Logistic Models | 2 | 2006 | 788 | 0.070 |
Why?
|
Milk | 1 | 2005 | 13 | 0.070 |
Why?
|
Xenobiotics | 1 | 2005 | 1 | 0.060 |
Why?
|
Population | 1 | 2005 | 8 | 0.060 |
Why?
|
Nervous System | 1 | 2005 | 15 | 0.060 |
Why?
|
Harm Reduction | 1 | 2004 | 14 | 0.060 |
Why?
|
Fetal Death | 1 | 2004 | 9 | 0.060 |
Why?
|
Maternal Age | 1 | 2004 | 15 | 0.060 |
Why?
|
Pyrenes | 1 | 2004 | 1 | 0.060 |
Why?
|
Demography | 1 | 2005 | 109 | 0.060 |
Why?
|
Community Health Centers | 1 | 2004 | 15 | 0.060 |
Why?
|
Counseling | 1 | 2004 | 99 | 0.060 |
Why?
|
Organothiophosphorus Compounds | 1 | 2004 | 8 | 0.060 |
Why?
|
Macaca mulatta | 3 | 2011 | 332 | 0.060 |
Why?
|
Air Pollutants, Occupational | 1 | 2003 | 4 | 0.060 |
Why?
|
Terrorism | 1 | 2003 | 4 | 0.060 |
Why?
|
Fires | 1 | 2003 | 4 | 0.060 |
Why?
|
Behavior Therapy | 1 | 2004 | 102 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 1133 | 0.060 |
Why?
|
Selenium | 1 | 2003 | 4 | 0.060 |
Why?
|
Methyl Parathion | 1 | 2002 | 1 | 0.060 |
Why?
|
Nitrophenols | 1 | 2002 | 3 | 0.050 |
Why?
|
Child Welfare | 1 | 2002 | 21 | 0.050 |
Why?
|
Decision Making | 1 | 2005 | 205 | 0.050 |
Why?
|
Health Status | 1 | 2005 | 402 | 0.050 |
Why?
|
Health Education | 1 | 2002 | 157 | 0.050 |
Why?
|
Veterans | 1 | 2002 | 66 | 0.050 |
Why?
|
Renal Tubular Transport, Inborn Errors | 1 | 2020 | 1 | 0.050 |
Why?
|
Polyuria | 1 | 2020 | 3 | 0.050 |
Why?
|
Parents | 1 | 2002 | 150 | 0.050 |
Why?
|
Hypothyroidism | 1 | 2020 | 13 | 0.050 |
Why?
|
Terpenes | 1 | 2020 | 6 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2012 | 61 | 0.050 |
Why?
|
Dialysis Solutions | 1 | 2020 | 6 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2002 | 195 | 0.040 |
Why?
|
Mouth | 1 | 2020 | 25 | 0.040 |
Why?
|
Canada | 1 | 2020 | 56 | 0.040 |
Why?
|
Hispanic Americans | 2 | 2005 | 949 | 0.040 |
Why?
|
Influenza A Virus, H3N2 Subtype | 2 | 2011 | 23 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2019 | 22 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 190 | 0.040 |
Why?
|
Urea | 1 | 2019 | 39 | 0.040 |
Why?
|
Age Distribution | 2 | 2010 | 210 | 0.040 |
Why?
|
Risk Assessment | 2 | 2020 | 1447 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 525 | 0.040 |
Why?
|
Plant Poisoning | 1 | 2018 | 1 | 0.040 |
Why?
|
Inhalation | 2 | 2009 | 8 | 0.040 |
Why?
|
Seeds | 1 | 2018 | 10 | 0.040 |
Why?
|
Scattering, Radiation | 1 | 2018 | 7 | 0.040 |
Why?
|
Workflow | 1 | 2018 | 23 | 0.040 |
Why?
|
Light | 1 | 2018 | 26 | 0.040 |
Why?
|
Particle Size | 1 | 2018 | 45 | 0.040 |
Why?
|
Mice | 3 | 2010 | 2524 | 0.040 |
Why?
|
Hydrolysis | 1 | 2017 | 41 | 0.040 |
Why?
|
Cholesterol Esters | 1 | 2017 | 37 | 0.040 |
Why?
|
Hydrocarbons, Chlorinated | 2 | 2009 | 4 | 0.040 |
Why?
|
Models, Statistical | 1 | 2018 | 176 | 0.040 |
Why?
|
India | 1 | 2017 | 65 | 0.040 |
Why?
|
Blood Proteins | 1 | 2016 | 19 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2016 | 294 | 0.030 |
Why?
|
Odds Ratio | 1 | 2017 | 480 | 0.030 |
Why?
|
Birds | 1 | 2014 | 3 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2017 | 911 | 0.030 |
Why?
|
Pesticides | 2 | 2009 | 202 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 71 | 0.030 |
Why?
|
Financing, Government | 1 | 2014 | 11 | 0.030 |
Why?
|
Acetylation | 1 | 2012 | 16 | 0.030 |
Why?
|
Drug Stability | 1 | 2012 | 8 | 0.030 |
Why?
|
Guanidine | 1 | 2012 | 3 | 0.030 |
Why?
|
Gels | 1 | 2012 | 32 | 0.030 |
Why?
|
Pilot Projects | 1 | 2014 | 536 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2011 | 3 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2011 | 17 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 64 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2011 | 65 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2011 | 76 | 0.030 |
Why?
|
Nucleoproteins | 1 | 2011 | 1 | 0.020 |
Why?
|
Plant Lectins | 1 | 2011 | 1 | 0.020 |
Why?
|
DNA Probes | 1 | 2011 | 19 | 0.020 |
Why?
|
Rats | 1 | 2015 | 1675 | 0.020 |
Why?
|
Clostridium botulinum type F | 1 | 2010 | 1 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2011 | 37 | 0.020 |
Why?
|
SNARE Proteins | 1 | 2010 | 4 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2011 | 60 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 90 | 0.020 |
Why?
|
Cross Reactions | 1 | 2010 | 5 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2010 | 15 | 0.020 |
Why?
|
Cell Line | 1 | 2011 | 462 | 0.020 |
Why?
|
Rabbits | 1 | 2011 | 199 | 0.020 |
Why?
|
Base Sequence | 1 | 2010 | 257 | 0.020 |
Why?
|
Lamivudine | 1 | 2009 | 2 | 0.020 |
Why?
|
Adenine | 1 | 2009 | 15 | 0.020 |
Why?
|
Influenza, Human | 1 | 2011 | 124 | 0.020 |
Why?
|
Ricinus | 1 | 2009 | 1 | 0.020 |
Why?
|
Indicator Dilution Techniques | 1 | 2009 | 2 | 0.020 |
Why?
|
Hemagglutinins | 1 | 2009 | 4 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2009 | 21 | 0.020 |
Why?
|
Clostridium botulinum type A | 1 | 2009 | 1 | 0.020 |
Why?
|
Serotyping | 1 | 2009 | 15 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2009 | 1 | 0.020 |
Why?
|
Analytic Sample Preparation Methods | 1 | 2009 | 1 | 0.020 |
Why?
|
Glycosylation | 1 | 2009 | 15 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2009 | 68 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2009 | 57 | 0.020 |
Why?
|
Virulence | 1 | 2009 | 22 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2009 | 64 | 0.020 |
Why?
|
Sweden | 1 | 2009 | 14 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2009 | 32 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 102 | 0.020 |
Why?
|
Binding Sites | 1 | 2009 | 132 | 0.020 |
Why?
|
Streptococcus oralis | 1 | 2008 | 1 | 0.020 |
Why?
|
Streptococcus mitis | 1 | 2008 | 2 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2009 | 150 | 0.020 |
Why?
|
Bacterial Typing Techniques | 1 | 2008 | 10 | 0.020 |
Why?
|
Enterococcus faecalis | 1 | 2008 | 10 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2008 | 21 | 0.020 |
Why?
|
Molecular Weight | 1 | 2008 | 43 | 0.020 |
Why?
|
Streptococcus pyogenes | 1 | 2008 | 16 | 0.020 |
Why?
|
Neutrophils | 1 | 2009 | 118 | 0.020 |
Why?
|
Radioisotope Dilution Technique | 1 | 2008 | 1 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 46 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2008 | 131 | 0.020 |
Why?
|
Proteome | 1 | 2008 | 39 | 0.020 |
Why?
|
Escherichia coli | 1 | 2008 | 87 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 11 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2008 | 49 | 0.020 |
Why?
|
Antibodies | 1 | 2007 | 57 | 0.020 |
Why?
|
Exotoxins | 1 | 2007 | 9 | 0.020 |
Why?
|
Bacillus anthracis | 1 | 2007 | 9 | 0.020 |
Why?
|
Travel | 1 | 2007 | 15 | 0.020 |
Why?
|
Thyrotropin | 1 | 2006 | 9 | 0.020 |
Why?
|
Thyroxine | 1 | 2006 | 16 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2009 | 166 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 167 | 0.020 |
Why?
|
Mass Screening | 1 | 2009 | 263 | 0.020 |
Why?
|
Benzofurans | 1 | 2005 | 5 | 0.020 |
Why?
|
Mercury | 1 | 2005 | 8 | 0.020 |
Why?
|
Metals | 1 | 2005 | 17 | 0.020 |
Why?
|
Occupations | 1 | 2004 | 10 | 0.020 |
Why?
|
Polymers | 1 | 2005 | 60 | 0.020 |
Why?
|
Hydrocarbons | 1 | 2003 | 2 | 0.010 |
Why?
|
Mutagens | 1 | 2003 | 5 | 0.010 |
Why?
|
New York City | 1 | 2003 | 14 | 0.010 |
Why?
|
Metals, Heavy | 1 | 2003 | 7 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 62 | 0.010 |
Why?
|
Mothers | 1 | 2004 | 87 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2007 | 926 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 550 | 0.010 |
Why?
|
Insect Control | 1 | 2002 | 1 | 0.010 |
Why?
|
United States Environmental Protection Agency | 1 | 2002 | 2 | 0.010 |
Why?
|
Geography | 1 | 2003 | 35 | 0.010 |
Why?
|
Local Government | 1 | 2002 | 5 | 0.010 |
Why?
|
Interinstitutional Relations | 1 | 2002 | 12 | 0.010 |
Why?
|
State Government | 1 | 2002 | 32 | 0.010 |
Why?
|
Data Collection | 1 | 2003 | 185 | 0.010 |
Why?
|
Continental Population Groups | 1 | 2004 | 239 | 0.010 |
Why?
|
Italy | 1 | 2002 | 15 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 2002 | 19 | 0.010 |
Why?
|
Accidents, Occupational | 1 | 2002 | 16 | 0.010 |
Why?
|
Time Factors | 1 | 2002 | 2181 | 0.010 |
Why?
|